International Isotopes Inc. Rebrands as Radnostix, Inc. to Reflect Strategic Healthcare Focus

summarizeSummary

International Isotopes Inc. has officially changed its corporate name to Radnostix, Inc., reflecting a strategic shift towards healthcare-focused radioisotope and theranostics products.

check_boxKey Events

• Corporate Name Change

  Effective December 23, 2025, International Isotopes Inc. officially changed its corporate name to Radnostix, Inc. by filing a Certificate of Amendment in Texas.

• Strategic Business Pivot

  The name change reflects an expanded business focus from industrial and energy-sector isotopes to a broader portfolio of radioisotope, theranostics, and related products primarily for healthcare applications.

• Ticker Symbol Unchanged

  The company's common stock will continue to trade under the current ticker symbol 'INIS' on the OTCQB marketplace, with a potential new symbol to be announced later.

auto_awesomeAnalysis

This 8-K filing announces a significant corporate name change for International Isotopes Inc. to Radnostix, Inc., effective December 23, 2025. The rebranding is not merely cosmetic; it signifies a strategic pivot in the company's business model. The company is shifting its primary focus from industrial and energy-sector related isotopes to a broader portfolio of radioisotope, theranostics, and related products, mainly concentrated on healthcare applications. For a micro-cap company, such a clear strategic redirection into a potentially higher-growth sector like healthcare theranostics can be a crucial development for its long-term prospects and investor appeal. While the ticker symbol 'INIS' remains unchanged for now, the new name better aligns with its evolving mission.